Who owns AVENUE THERAPEUTICS INC?
- Ticker: ATXI
- CUSIP Number: 05360l403
Tip: Access positions for across all investors
Analyze quarterly positions in Avenue Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avenue Therapeutics stock
Who bought or sold AVENUE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 140k | $280k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 41k | $82k | 100% | Dec 2024 |
|
| UBS Group | 7.9k | $16k | 29% | Dec 2024 |
|
| Tower Research Capital | 3.1k | $6.2k | 78% | Dec 2024 |
|
| Wells Fargo & Company | 500.00 | $1.0k | -11% | Dec 2024 |
|
| Bank of America Corporation | 14.00 | $28.000000 | 40% | Dec 2024 |
|
| SBI Securities | 9.00 | $18.000000 | 100% | Dec 2024 |
|
Who sold out of Avenue Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2024 | 115k | $286k |
| Sabby Management | Sep 2024 | 63k | $157k |
| Moss Adams Wealth Advisors | Sep 2024 | 11k | $27k |